NASDAQ:ADIL

Adial Pharmaceuticals Earning Date

USA |NASDAQ |USD

ADIL Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 13, 2021 (est) Sep 30, 2021 - $-0.25 $-0.24
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 13, 2021 (est) Sep 30, 2021 - $0.00 $0.00

Adial Pharmaceuticals's next estimated earnings date (based on same quarter last year's date) is Nov 13, 2021 for the fiscal quarter ending Sep 30, 2021.

ADIL Earnings Date & History Chart

ADIL Earnings & Revenue Forecast

ADIL Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 2 $-0.21 $-0.22 $-0.21
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 2 $-0.97 $-0.97 $-0.97
Dec 2022 2 $-0.76 $-0.83 $-0.70

ADIL Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.21 $-0.18 $-0.14
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.97 $-0.87 $-0.77
Dec 2022 0 / 0 $-0.76 $-0.68 $-0.54

ADIL Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 1 $0.00 $0.00 $0.00
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 1 $0.00 $0.00 $0.00
Dec 2022 1 $0.00 $0.00 $0.00

ADIL Earnings Date & Revenue History

ADIL Earnings History

|
Show More
Show More

ADIL Revenue History

|
Show More
Show More

Adial Pharmaceuticals Next Earnings Date & Report

ADIL Aug 2021 (FQ) Earnings Date & Report Preview

ADIL's next estimated earnings date (based on same quarter last year's report date) is Nov 13, 2021 for the fiscal quarter ending Sep 30, 2021.

Adial Pharmaceuticals Previous Earnings Dates & Reports

ADIL Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Adial Pharmaceuticals's previous earnings date was Aug 12, 2021 for its fiscal quarter ended Jun 30, 2021.

ADIL's earnings per share (EPS) was $-0.25, missing the consensus analysts forecast of $-0.21 by -21.95%.

The EPS was higher than the previous fiscal quarter (Mar 2021) by -16.67%, and lower than the same period a year before (Jun 2020) by 56.25%.

Revenues were $0.00.

The company reported a net income of $-4.44M.

Free cash flow for the quarter was $-3.24M , compared to $-2.87M last quarter and $-985.17K a year before.

ADIL ended the quarter with $273.29K in total debt, a decrease of -12.69% compared to the previous quarter.

ADIL Previous Earnings Date & Report Recap: Dec 2020 (FY)

Adial Pharmaceuticals's previous annual earnings date was Mar 22, 2021 for its fiscal year ended Dec 31, 2020.

ADIL's earnings per share (EPS) was $-0.87, beating the consensus analysts forecast of $-0.89 by -2.25% , and higher than the previous year's EPS (Dec 2019) by -3.33%.

Revenues were $0.00.

The company reported a net income of $-10.89M.

Adial Pharmaceuticals reported a free cash flow of $-7.63M for its fiscal year, compared to $-6.34M a year ago.